Skip to main content
logo
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.45
-0.40 (-2.52%)
At close: Aug 10, 2026, 4:00 PM EDT
15.50
+0.05 (0.32%)
After-hours: Aug 10, 2026, 6:35 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Research, Development and Commercialization of Therapeutic Drugs
283.06M235.13M175.51M134.03M45.61M
Total
283.06M235.13M175.51M134.03M45.61M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
263.84M210.10M157.96M102.46M45.49M
Japan
19.21M25.04M17.56M31.48M-
Other
---89.00K117.00K
Total
283.06M235.13M175.51M134.03M45.61M